Revolution Medicines H-1B Visa Sponsorship 2026
Pharma & biotech · H-1B sponsor · FY2017–2026
🏢 Redwood City, CA HQ🌐 revolutionmedicines.com
Does Revolution Medicines sponsor H-1B visas and green cards?
Yes. Revolution Medicines has filed 90 H-1B LCAs and 4 PERM green-card cases with the U.S. Department of Labor between FY2017 and FY2026. In FY2025–2026 Revolution Medicines filed 41 H-1B LCAs at a median base salary of $181,500, about 49% above the national H-1B median of $121,966 for the same period, and 3 green-card cases were decided.
H-1B pay & filings by year
Median base salary (line) and H-1B filing volume (bars), by fiscal year
Show the numbers behind this chart
| Fiscal year | H-1B LCA filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 28 | $185k |
| FY2025 | 13 | $178k |
| FY2024 | 19 | $168k |
| FY2023 | 16 | $125k |
| FY2022 | 9 | $135k |
| FY2021 | 1 | $190k |
| FY2020 | 2 | $118k |
| FY2019 | 1 | $118k |
| FY2017 | 1 | $103k |
A fiscal year marked partial is still in progress, so its total is lower than a complete year and the two are not comparable.
H-1B wage floor & filing outcomes
What this employer pays against the DOL legal minimum, how senior the roles are, and how the filings were decided
Roles they file for
- 1Senior Associate, Regulatory Affairs3$125k
- 2Senior Clinical Data Manager3$178k
- 3Senior Scientist I, Dmpk3$168k
- 4Associate Director, Biostatistics2$213k
- 5Associate Director, Clinical Data Management2$180k
- 6Associate Principal Statistical Analyst2$189k
- 7Clinical Pk Manager2$159k
- 8Director, Clinical Data Science2$223k
Where they hire
Green-card (PERM) pay & filings by year
Median green-card offer (line) and PERM filing volume (bars), by fiscal year †
Show the numbers behind this chart
| Fiscal year | PERM filings | Median base salary |
|---|---|---|
| FY2025 | 3 | $170k |
| FY2024 | 1 | $195k |
Green-card route and outcomes
Worker backgrounds · FY2017–2024
Where their green-card (PERM) workers studied & came from
Patents
- Granted
- 42
- US patents
- Published, not yet granted
- 105
- applications
- Most recent grant
- March 24, 2026
- Top area
- Heterocyclic compounds26
Pay against the local market
Revolution Medicines’s 10 most-filed occupations and metros. Its median base salary is 120% of the local BLS median for the same work.
| Occupation | Metro | Filings | Revolution Medicines pay | Local BLS median‡ | vs market |
|---|---|---|---|---|---|
| Statisticians | San Francisco, CA | 14 | $186,896 | $148,646 | 126% |
| Biological Scientists, All Other | San Francisco, CA | 13 | $139,038 | $131,139 | 106% |
| Biochemists and Biophysicists | San Francisco, CA | 10 | $146,602 | $136,396 | 107% |
| Data Scientists | San Francisco, CA | 10 | $191,720 | $163,438 | 117% |
| Medical Scientists | San Francisco, CA | 6 | $140,567 | $137,650 | 102% |
| Chemists | San Francisco, CA | 5 | $130,400 | $115,680 | 113% |
| Compliance Officers | San Francisco, CA | 5 | $156,900 | $101,792 | 154% |
| Data Scientists | Tampa, FL | 3 | $196,293 | $108,740 | 181% |
| Accountants and Auditors | San Francisco, CA | 2 | $133,750 | $103,100 | 130% |
| Logisticians | San Francisco, CA | 2 | $99,600 | $106,120 | 94% |
About Revolution Medicines
- Legal name
- Revolution Medicines, Inc.
- Listed
- Nasdaq: RVMD
- Incorporated in
- Delaware
- Headquarters
- 700 Saginaw Dr, Redwood City, CA 94063
- Industry
- Pharma & biotech
- Employees (US, est)
- 513 (2024)
- Revenue FY2025
- $0M
- Net income FY2025
- $-1.1B -89% from $-600M
- R&D FY2025
- $987M
Revolution Medicines pays a median H-1B base of $167,895 across FY2017–2026, about 55% above the typical Pharma & biotech sponsor.
H-1B sponsors similar to Revolution Medicines
| Employer | Filings, all years | Recent filings | Median base | New employment | Level III-IV roles |
|---|---|---|---|---|---|
| Daiichi Sankyo | 125 | 53 | $162k | 18 | 55% |
| Sarepta Therapeutics | 122 | 40 | $124k | 11 | 48% |
| Mylan | 121 | 24 | $118k | 9 | 63% |
| Revolution Medicines | 90 | 41 | $182k | 14 | 78% |
| Sumitomo Pharma America | 89 | 25 | $166k | 3 | 78% |
| Agios Pharmaceuticals | 88 | 17 | $165k | 2 | — |
| AmbioPharm | 87 | 3 | $70k | 1 | — |
